genOway Société anonyme (EPA: ALGEN)

Market Cap	34.51M
Revenue (ttm)	28.08M
Net Income (ttm)	1.26M
Shares Out	9.01M
EPS (ttm)	n/a
PE Ratio	27.48
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,518
Open	3.840
Previous Close	3.840
Day's Range	3.830 - 3.930
52-Week Range	3.240 - 4.910
Beta	0.51
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 24, 2024

About genOway Société anonyme

genOway Société anonyme, a biotechnology company, engages in the development and commercialization of custom genetically modified mouse, rat, and cell line models worldwide. It produces customized mouse models, such as knockout (KO) and knockin (KI) mouse models; customized rat models, including constitutive and conditional KO, point mutation KI, and quick KI rat models; and customized cell lines, such as constitutive and inducible KO, point mutation KI, reporter KI, quick KI, and KI cell lines. The company also offers humanized immune checkpoi...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1999
• Employees: 133
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALGEN

Financial Performance

In 2023, genOway Société anonyme's revenue was 26.51 million, an increase of 25.70% compared to the previous year's 21.09 million. Earnings were 1.57 million, an increase of 101.55%.